Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive neurodegenerative disease
resulting in death in 2 to 4 years in most cases. There are several clinical subtypes of ALS …

Abstract Purpose of Review: This article reviews the clinical features, diagnostic pathway,
therapies, and current understanding of the pathophysiology of amyotrophic lateral sclerosis …

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurological disease affecting
both upper and lower motor neurons. In the United States alone, there are 16,000–20,000 …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is
characterized by degeneration of both upper and lower motor neurons and subsequent …

Amyotrophic lateral sclerosis (ALS) was first described 134 years ago. While still incurable,
significant progress has been made in understanding the pathophysiology of the disease …

ALS is a relentlessly progressive and fatal disease, with no curative therapies available to
date. Symptomatic and palliative care, provided in a multidisciplinary context, still remains …

Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that affects upper
and lower motor neurons in the brain and spinal cord, with progressive weakness and …

Background Despite being one of the most devastating diseases known, there is little
evidence for diagnosing and managing patients with amyotrophic lateral sclerosis (ALS) …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
characterized by loss of motor neurons in the spinal cord, brain stem and motor cortex which …

With the acceleration in our understanding of ALS and the related motor neuron disease has
come even greater challenges in reconciling all of the proposed pathogenic mechanisms …